These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31208060)

  • 1. Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial.
    Maki S; Tanaka H; Tsuji M; Furuhashi F; Magawa S; Kaneda MK; Nii M; Tanaka K; Kondo E; Tamaru S; Ogura T; Nishimura Y; Endoh M; Kimura T; Kotani T; Sekizawa A; Ikeda T
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31208060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
    Umekawa T; Maki S; Kubo M; Tanaka H; Nii M; Tanaka K; Osato K; Kamimoto Y; Tamaru S; Ogura T; Nishimura Y; Kodera M; Minamide C; Nishikawa M; Endoh M; Kimura T; Kotani T; Nakamura M; Sekizawa A; Ikeda T;
    BMJ Open; 2018 Oct; 8(10):e020948. PubMed ID: 30381311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial.
    Furuhashi F; Tanaka H; Maki S; Tsuji M; Magawa S; Kaneda MK; Nii M; Tanaka K; Ogura T; Nishimura Y; Endoh M; Kimura T; Kotani T; Sekizawa A; Ikeda T;
    J Matern Fetal Neonatal Med; 2021 Nov; 34(22):3709-3715. PubMed ID: 31736381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and dose-finding trial of tadalafil administered for fetal growth restriction: A phase-1 clinical study.
    Kubo M; Tanaka H; Maki S; Nii M; Murabayashi N; Osato K; Kamimoto Y; Umekawa T; Kondo E; Ikeda T
    J Obstet Gynaecol Res; 2017 Jul; 43(7):1159-1168. PubMed ID: 28718213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase-1 clinical study of tadalafil administered for selective fetal growth restriction in twin pregnancy.
    Magawa S; Nii M; Tanaka H; Furuhashi F; Maki S; Kubo M; Tanaka K; Kondo E; Ikeda T
    J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1075-1082. PubMed ID: 31131648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb).
    Maki S; Tanaka H; Takakura S; Nii M; Tanaka K; Ogura T; Kotera M; Nishimura Y; Tamaru S; Ushida T; Tanaka Y; Kikuchi N; Kinjo T; Kawamura H; Takano M; Nakamura K; Suga S; Kasai M; Yasui O; Nagao K; Maegawa Y; Kotani T; Endo M; Yasuhi I; Aoki S; Aoki Y; Yoshida Y; Nakata M; Sekizawa A; Ikeda T
    BMJ Open; 2022 Jun; 12(6):e054925. PubMed ID: 35701067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes.
    Kubo M; Umekawa T; Maekawa Y; Tanaka H; Nii M; Murabayashi N; Osato K; Kamimoto Y; Ikeda T
    J Obstet Gynaecol Res; 2017 Feb; 43(2):291-297. PubMed ID: 27987345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice.
    Sekimoto A; Tanaka K; Hashizume Y; Sato E; Sato H; Ikeda T; Takahashi N
    Biochem Biophys Res Commun; 2020 Jan; 521(3):769-774. PubMed ID: 31703840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental growth factor as a predictor of the efficacy of tadalafil treatment for fetal growth restriction.
    Kubo-Kaneda M; Tanaka H; Maki S; Nii M; Umekawa T; Osato K; Kamimoto Y; Kondo E; Ikeda T
    J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2879-2882. PubMed ID: 29580120
    [No Abstract]   [Full Text] [Related]  

  • 10. Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice.
    Yoshikawa K; Umekawa T; Maki S; Kubo M; Nii M; Tanaka K; Tanaka H; Osato K; Kamimoto Y; Kondo E; Ikemura K; Okuda M; Katayama K; Miyoshi T; Hosoda H; Ma N; Yoshida T; Ikeda T
    Am J Hypertens; 2017 Dec; 31(1):89-96. PubMed ID: 28992178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
    Tachibana R; Umekawa T; Yoshikawa K; Owa T; Magawa S; Furuhashi F; Tsuji M; Maki S; Shimada K; Kaneda MK; Nii M; Tanaka H; Tanaka K; Kamimoto Y; Kondo E; Kato I; Ikemura K; Okuda M; Ma N; Miyoshi T; Hosoda H; Endoh M; Kimura T; Ikeda T
    Sci Rep; 2019 Jan; 9(1):234. PubMed ID: 30659198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction.
    Tanaka H; Kubo M; Nii M; Maki S; Umekawa T; Ikeda T
    J Obstet Gynaecol Res; 2017 Jul; 43(7):1205-1208. PubMed ID: 28503744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease.
    Tanaka K; Tanaka H; Maki S; Kubo M; Nii M; Magawa S; Hatano F; Tsuji M; Osato K; Kamimoto Y; Umekawa T; Ikeda T
    J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2460-2462. PubMed ID: 29415591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model.
    Walton RB; Reed LC; Estrada SM; Schmiedecke SS; Villazana-Kretzer DL; Napolitano PG; Ieronimakis N
    Hypertension; 2018 Jul; 72(1):167-176. PubMed ID: 29735634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety trial of tadalafil administered for the treatment of preeclampsia.
    Furuhashi FH; Tanaka H; Kaneda MK; Maki S; Nii M; Umekawa T; Osato K; Kamimoto Y; Ikeda T
    J Matern Fetal Neonatal Med; 2020 Jan; 33(1):167-170. PubMed ID: 29886797
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal and fetal risk factors affecting perinatal mortality in early and late fetal growth restriction.
    Demirci O; Selçuk S; Kumru P; Asoğlu MR; Mahmutoğlu D; Boza B; Türkyılmaz G; Bütün Z; Arısoy R; Tandoğan B
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):700-4. PubMed ID: 26700988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction.
    Maki S; Kato I; Enomoto N; Takakura S; Nii M; Tanaka K; Tanaka H; Hori S; Matsuda K; Ueda Y; Sawada H; Hirayama M; Sudo A; Ikeda T
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32413997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified myocardial performance index and its prognostic significance for adverse perinatal outcome in early and late onset fetal growth restriction.
    Alici Davutoglu E; Ozel A; Oztunc F; Madazli R
    J Matern Fetal Neonatal Med; 2020 Jan; 33(2):277-282. PubMed ID: 30033784
    [No Abstract]   [Full Text] [Related]  

  • 20. Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.
    Palmer KR; Mockler JC; Davies-Tuck ML; Miller SL; Goergen SK; Fahey MC; Anderson PJ; Groom KM; Wallace EM
    BMJ Open; 2019 Jun; 9(6):e028243. PubMed ID: 31230020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.